Viking Therapeutics, Inc. - COMMON STOCK (VKTX)

CUSIP: 92686J106

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class
Equity / COMMON STOCK
Shares outstanding
113,177,462
Total 13F shares
54,005
Share change
+54,005
Total reported value
$384,000
Price per share
$7.10
Number of holders
5
Value change
+$384,000
Number of buys
5

Quarterly Holders Quick Answers

What is CUSIP 92686J106?
CUSIP 92686J106 identifies VKTX - Viking Therapeutics, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q2 2015

As of 30 Jun 2015, Viking Therapeutics, Inc. - COMMON STOCK (VKTX) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 54,005 shares. The largest 5 holders included GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, KCG Holdings, Inc., BlackRock Investment Management, LLC, and Tower Research Capital LLC (TRC). This page lists 5 institutional shareholders reporting positions in this security for the Q2 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.